Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil for postoperative analgesia after gastrointestinal surgery
ChiCTR2400091677Phase 4Not yet recruiting
- Sponsor
- Dazhou Central Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in postoperative pain (4 arms), sponsored by Dazhou Central Hospital. Primary endpoints: Pain score, Total and effective analgesic pump compressions and 1 more. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400091677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091677.